CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...